Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-25

FDA Approved: JUNEL FE 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for JUNEL FE 28 DAY (norethindrone acetate and ethinyl estradiol and ferrous fumarate) from Teva Pharmaceuticals USA, In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUNEL FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for JUNEL FE 28 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)